The purpose of this study is to determine if Dimebon is safe and effective in patients with mild to moderate Alzheimer's disease on Donepezil.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
1,003
Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL)
Time frame: Week 52
Alzheimer's Disease Assessment Scale - Cognitive Subscale
Time frame: Week 52
Clinician's Interview Based Impression of Change, plus caregiver input (CIBIC-plus)
Time frame: Week 52
Neuropsychiatric Inventory (NPI)
Time frame: Week 52
Resource Utilization in Dementia Lite (RUD lite)
Time frame: Week 52
Euro Quality of Life 5 (EQ-5D)
Time frame: Week 52
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Phoenix, Arizona, United States
Unnamed facility
Sun City, Arizona, United States
Unnamed facility
Tucson, Arizona, United States
Unnamed facility
Costa Mesa, California, United States
Unnamed facility
Encino, California, United States
Unnamed facility
Escondido, California, United States
Unnamed facility
Fresno, California, United States
Unnamed facility
Garden Grove, California, United States
Unnamed facility
La Jolla, California, United States
Unnamed facility
Los Alamitos, California, United States
...and 91 more locations